Vogenx, Inc.
Vogenx is a clinical-stage biopharmaceutical company based in Raleigh, North Carolina, developing mizagliflozin for post-bariatric hypoglycemia, gastroparesis, and GIP-dependent Cushing's Syndrome.
8-KSep 22Latest SEC filing, period to Sep 21
Sep 22Latest story